- Home
- AIFF vs BNGO Comparison
AIFF vs BNGO Comparison
Compare AIFF & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIFF
- BNGO
- Stock Information
- Founded
- AIFF 2006
- BNGO 2003
- Country
- AIFF Canada
- BNGO United States
- Employees
- AIFF N/A
- BNGO N/A
- Industry
- AIFF
- BNGO Biotechnology: Laboratory Analytical Instruments
- Sector
- AIFF
- BNGO Industrials
- Exchange
- AIFF NYSE
- BNGO Nasdaq
- Market Cap
- AIFF 26.6M
- BNGO 24.3M
- IPO Year
- AIFF N/A
- BNGO 2018
- Fundamental
- Price
- AIFF $3.15
- BNGO $0.21
- Analyst Decision
- AIFF
- BNGO Hold
- Analyst Count
- AIFF 0
- BNGO 3
- Target Price
- AIFF N/A
- BNGO $1.00
- AVG Volume (30 Days)
- AIFF 324.9K
- BNGO 14.8M
- Earning Date
- AIFF 02-21-2025
- BNGO 03-04-2025
- Dividend Yield
- AIFF N/A
- BNGO N/A
- EPS Growth
- AIFF N/A
- BNGO N/A
- EPS
- AIFF N/A
- BNGO N/A
- Revenue
- AIFF $74,000.00
- BNGO $33,334,000.00
- Revenue This Year
- AIFF N/A
- BNGO N/A
- Revenue Next Year
- AIFF N/A
- BNGO $6.18
- P/E Ratio
- AIFF N/A
- BNGO N/A
- Revenue Growth
- AIFF N/A
- BNGO N/A
- 52 Week Low
- AIFF $1.86
- BNGO $0.19
- 52 Week High
- AIFF $15.90
- BNGO $1.40
- Technical
- Relative Strength Index (RSI)
- AIFF 58.70
- BNGO 41.68
- Support Level
- AIFF $1.86
- BNGO $0.19
- Resistance Level
- AIFF $2.74
- BNGO $0.38
- Average True Range (ATR)
- AIFF 0.48
- BNGO 0.05
- MACD
- AIFF 0.02
- BNGO -0.00
- Stochastic Oscillator
- AIFF 32.74
- BNGO 8.00
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support better outcomes for people suffering from mental illnesses and cognitive disorders.
About BNGO Bionano Genomics Inc.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.